In the United States, nearly 80 percent of clinical trials fail to meet their original enrollment … How Pharma Marketing Impacts Clinical Trial SuccessRead more
Author: Jayshree Gondane
Jayshree Gondane,
BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
Why Patient Recruitment Is the Biggest Problem in Clinical Trials Today
Patient recruitment remains the single most persistent bottleneck in clinical trials today. Despite advances in trial … Why Patient Recruitment Is the Biggest Problem in Clinical Trials TodayRead more
Common Clinical Trial Mistakes Pharma Companies Keep Repeating
Despite decades of regulatory guidance, expanded access to data, and repeated public postmortems of failed programs, … Common Clinical Trial Mistakes Pharma Companies Keep RepeatingRead more
How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical Market
In the United States, drug approval timelines are becoming harder to predict. Despite record investment in … How Misaligned R&D and Marketing Delay Drug Approvals in the U.S. Pharmaceutical MarketRead more
Why Great Science Often Fails Commercially in Pharma
In the United States, bringing a new drug to market now costs more than $2 billion on average … Why Great Science Often Fails Commercially in PharmaRead more
The Real Reasons Promising Drugs Fail Before Phase II
Drug development is one of the most capital-intensive and high-risk sectors in the pharmaceutical industry. While … The Real Reasons Promising Drugs Fail Before Phase IIRead more
How Poor Clinical Trial Recruitment Is Quietly Killing Drug Development
In 2024, nearly 85 percent of U.S. clinical trials failed to enroll sufficient participants on schedule, … How Poor Clinical Trial Recruitment Is Quietly Killing Drug DevelopmentRead more
Why So Many Pharma Companies Get Stuck in Phase I Clinical Trials
In the United States, drug development rarely collapses at the finish line. It slows, fragments, and … Why So Many Pharma Companies Get Stuck in Phase I Clinical TrialsRead more
Designing Content Ecosystems for Specialty Brands
In today’s competitive pharmaceutical landscape, specialty brands face unique challenges in reaching and engaging healthcare professionals … Designing Content Ecosystems for Specialty BrandsRead more
Patient Education Pipelines Built With Automation
Patient education is a cornerstone of modern healthcare, impacting treatment adherence, clinical outcomes, and patient satisfaction. … Patient Education Pipelines Built With AutomationRead more